Krishnan Suma 的 Form 4 申報
Krystal Biotech, Inc.（KRYS），2023/6/2 申報
- 申報編號
- 0001298711-23-000015
- 申報時間
- 2023/6/2
- 交易日
- 2023/5/31
- 申報延遲
- 2 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 6 筆非衍生性交易。公開市場賣出合計 $581.0 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Krishnan SumaCIK 0001298711 | 董事、高階主管（President, R&D）、持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/5/31 | Common Stock | S賣出處分 | −20,143 | $115.98F1 | −$2,336,185.14 | 1,629,063 | 直接 | 重複申報 |
| 2023/5/31 | Common Stock | S賣出處分 | −4,557 | $116.86F2 | −$532,531.02 | 1,624,506 | 直接 | 重複申報 |
| 2023/5/31 | Common Stock | S賣出處分 | −300 | $117.57F3 | −$35,271 | 1,624,206 | 直接 | 重複申報 |
| 2023/5/31 | Common Stock | S賣出處分 | −18,884 | $116.00F1 | −$2,190,544 | 1,690,454 | 間接 | 重複申報 |
| 2023/5/31 | Common Stock | S賣出處分 | −5,716 | $116.95F6 | −$668,486.2 | 1,684,738 | 間接 | 重複申報 |
| 2023/5/31 | Common Stock | S賣出處分 | −400 | $117.61F7 | −$47,044 | 1,684,338 | 間接 | 重複申報 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The transaction was executed in multiple trades ranging from $115.5200 to $116.5100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 2 筆交易的價格引用這則附註。
- F2
The transaction was executed in multiple trades ranging from $116.5200 to $117.5100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The transaction was executed in multiple trades ranging from $117.5500 to $117.6000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 1 筆交易的價格引用這則附註。
- F6
The transaction was executed in multiple trades ranging from $116.5200 to $117.5000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 1 筆交易的價格引用這則附註。
- F7
The transaction was executed in multiple trades ranging from $117.5500 to $117.7200. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
表 I 有 1 筆交易的價格引用這則附註。